Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 520 | 580↑11.4% | 667↑15.1% | 608↓8.9% | 662↑8.9% |
| Gross Profit | 468 | 505↑7.9% | 580↑14.9% | 524↓9.7% | 584↑11.5% |
| Operating Income | 174 | 86↓50.5% | 46↓46.4% | -5↓111.4% | 82↑1649.9% |
| Net Income | 127 | 53↓57.9% | 61↑13.6% | 1↓97.8% | 74↑5512.8% |
| EBITDA | 211 | 129↓38.6% | 153↑18.7% | 90↓41.3% | 178↑98.0% |
| EPS Diluted | 2.36 | 0.98↓58.5% | 1.04↑6.1% | 0.02↓97.7% | 1.32↑5469.6% |